top of page
Subsequent Applications
BI’s technology will address (a) other autoimmune diseases such as Diabetes Mellitus type-1 (b) transplant patients (solid organs) thus minimizing cytotoxic drugs dozes.
bottom of page
BI’s technology will address (a) other autoimmune diseases such as Diabetes Mellitus type-1 (b) transplant patients (solid organs) thus minimizing cytotoxic drugs dozes.